Needham & Company LLC Reaffirms “Hold” Rating for Lexicon Pharmaceuticals (NASDAQ:LXRX)
Lexicon Pharmaceuticals (NASDAQ:LXRX – Get Free Report)‘s stock had its “hold” rating reissued by investment analysts at Needham & Company LLC in a research report issued on Monday,Benzinga reports. Separately, HC Wainwright reiterated a “buy” rating and issued a $4.00 target price on shares of Lexicon Pharmaceuticals in a research report on Monday. One equities […]
Lexicon Pharmaceuticals (NASDAQ:LXRX – Get Free Report)‘s stock had its “hold” rating reissued by investment analysts at Needham & Company LLC in a research report issued on Monday,Benzinga reports. Separately, HC Wainwright reiterated a “buy” rating and issued a $4.00 target price on shares of Lexicon Pharmaceuticals in a research report on Monday. One equities […]
